DAPK1 and B-cell chronic lymphocytic leukemia: We believe the discrepancies in our data may be explained somewhat by the limited culture conditions and suggest that more elaborate and developed models would be necessary to more fully recapitulate and understand CLL cell proliferation and apoptosis in response to ibrutinib and DAPK inhibition in vitro.